Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression
The FEBS Journal · 2025-04 · 292 (7) · 1558-1572
DOI: 10.1111/febs.17270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 16.09.2024. Verfasst von Sylvia Mangani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, G…. Hauptthemen laut MEDLINE: Extracellular Matrix, Breast Neoplasms, Estrogen Receptor beta, Estrogen Receptor alpha. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, University of Patras, European Commission.
Abstract (Originalsprache)
Cancer remains a significant global health concern. Breast cancer is a multifaceted and prevalent disease influenced by several factors, among which estrogen receptors (ERs) and the extracellular matrix (ECM) play pivotal roles. ERs, encompassing ERα and ERβ, exert significant diversity on tumor behavior, cell signaling, invasion, and metastatic potential, thus guiding breast cancer prognosis. Understanding the multifunctional connections between ERs and ECM that mediate the dynamics of tumor microenvironment is vital for unraveling the complexity of breast cancer pathobiology and identifying novel therapeutic targets. This critical review delves into the intricate nature of ERs, emphasizing their structural isoforms and the consequential impact on breast cancer outcomes. A detailed examination of ER‐mediated cell signaling pathways reveals how differential expression of ERα and ERβ isoforms influence breast cancer cell behavior. The functional ERs‐matrix interactions emerge as a pivotal factor in modulating epigenetic mechanisms of breast cancer cells, orchestrating changes in cellular phenotype and expression patterns of matrix modulators. Specifically, ERα isoforms are shown to regulate ECM signaling cascades, while the effects of ECM components on ERα activity highlight a bidirectional regulatory axis. The diversity of ERβ isoforms is also highlighted, illustrating their distinct contribution to ECM‐mediated cellular responses. This review underscores the complex interplay between ERα/β isoforms and the ECM, shedding light onto the potential therapeutic strategies targeting these interactions to improve breast cancer management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, Greece.
ORCID-Profile: Zoi Piperigkou, Nikos K Karamanos
Förderung
- European Union
- University of Patras
- European Commission
Zitieren
APA
Mangani, S., Piperigkou, Z., Koletsis, N. E., Ioannou, P., & Karamanos, N. K. (2025). Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression. The FEBS Journal, 292(7), 1558-1572. https://doi.org/10.1111/febs.17270
Vancouver
Mangani S, Piperigkou Z, Koletsis NE, Ioannou P, Karamanos NK. Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression. The FEBS Journal. 2025;292(7):1558-1572. doi:10.1111/febs.17270
BibTeX
@article{Mangani2025,
author = {Mangani, Sylvia and Piperigkou, Zoi and Koletsis, Nikolaos E and Ioannou, Paraskevi and Karamanos, Nikos K},
title = {Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression},
journal = {The FEBS Journal},
year = {2025},
volume = {292},
number = {7},
pages = {1558--1572},
doi = {10.1111/febs.17270}
}
EUVIMED